复星医药：向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）

证券之星06-05 17:18

证券之星消息，复星医药(600196)06月05日在投资者关系平台上答复投资者关心的问题。

投资者提问：啥时分红，亏大发了，尽快分红

复星医药回复：投资者您好！公司2025年度利润分配预案尚待2025年度股东会（将于2026年6月16日召开）批准，本次利润分配预案为向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）。有关本次分红的具体安排，请留意公司后续发布的临时公告。感谢您对公司的关注。

本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。

相关 ETF

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2641611953?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-05 17:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2641611953","market":"sh","top_or_hot":-1,"title":"复星医药：向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/600196\">复星医药</a>(600196)06月05日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：啥时分红，亏大发了，尽快分红</p><p><a href=\"https://laohu8.com/S/02196\">复星医药</a>回复：投资者您好！公司2025年度利润分配预案尚待2025年度股东会（将于2026年6月16日召开）批准，本次利润分配预案为向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）。有关本次分红的具体安排，请留意公司后续发布的临时公告。感谢您对公司的关注。</p><p>本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。</p><h2>相关 ETF</h2><p><img src=\"https://static.stockstar.com/etf/15991520260605.png\"/><img src=\"https://static.stockstar.com/etf/51031020260605.png\"/><img src=\"https://static.stockstar.com/etf/51201020260605.png\"/><img src=\"https://static.stockstar.com/etf/51608020260605.png\"/></p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药：向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药：向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-05 17:18 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026060500029774.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，复星医药(600196)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问：啥时分红，亏大发了，尽快分红复星医药回复：投资者您好！公司2025年度利润分配预案尚待2025年度股东会（将于2026年6月16日召开）批准，本次利润分配预案为向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）。有关本次分红的具体安排，请留意公司后续发布...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026060500029774.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CYB","symbol_name":"人民币ETF-WisdomTree Dreyfus","start_time":0,"source_url":"https://stock.stockstar.com/RB2026060500029774.shtml","article_id":"2641611953","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2641611953","pubTimestamp":1780651117,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，复星医药(600196)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问：啥时分红，亏大发了，尽快分红复星医药回复：投资者您好！公司2025年度利润分配预案尚待2025年度股东会（将于2026年6月16日召开）批准，本次利润分配预案为向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）。有关本次分红的具体安排，请留意公司后续发布的临时公告。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600196":"复星医药","CYB":"人民币ETF-WisdomTree Dreyfus","BK0183":"MSCI概念","BK0188":"融资融券","02196":"复星医药","BK0012":"证金概念","BK0187":"一线龙头","BK0028":"国家队","BK1191":"制药","BK1593":"医美概念股","BK0175":"白马股","BK0060":"抗癌","BK1515":"抗疫概念","BK0196":"行业龙头","BK0239":"医药制造","BK0096":"民营医院"},"translate_title":"Fosun Pharma: cash dividend of RMB3.90 (before tax) for every 10 shares to shareholders who can participate in the distribution on the registration date specified in the announcement on the implementation of equity distribution","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":1.5,"CYB":0.6,"MUCmain":1.5,"02196":1.5,"UCmain":1.5,"MCNHmain":1.5,"CNHmain":1.5},"content_text":"证券之星消息，复星医药(600196)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问：啥时分红，亏大发了，尽快分红复星医药回复：投资者您好！公司2025年度利润分配预案尚待2025年度股东会（将于2026年6月16日召开）批准，本次利润分配预案为向权益分派实施公告指定的股权登记日可参与分配的股东每10股派发现金红利人民币3.90元（税前）。有关本次分红的具体安排，请留意公司后续发布的临时公告。感谢您对公司的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。相关 ETF","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2641611953","isCrawlerRequest":true}